Orthopedic surgeon Sunny Patel, MD, performed a new knee cartilage replacement procedure at Burlington, N.C.-based Alamance Regional Medical Center, the Times-News reports.

Biological Industries USA and StemExpress partnered to distribute StemExpress' human bone marrow-derived mesenchymal stem cells.

Cytokines present in umbilical cord blood-derived products can stimulate cellular processes necessary for bone regeneration, according to a study in Regenerative Medicine.

The global orthobiologics market is projected to reach $10.1 billion by 2025, according to Market Insights Reports.

Anika Therapeutics appointed Susan Vogt to its board of directors.

Degenerative disc disease patients who received intradiscal injections of SpinalCyte's CybroCell showed sustained pain relief improvement and greater back mobility after 12 months, according to the results of a phase 1/2 clinical trial.

Regentis Biomaterials expanded its clinical trial of GelrinC for the treatment of articular knee cartilage damage to 11 U.S. sites.

BoneSupport launched its own U.S. distributor network.

Three Los Angeles-based Cedars-Sinai investigators developed a method to harness stem cells to regrow tissue damaged by major trauma. The Department of Defense and National Institutes of Health awarded the researchers $8 million in grants.

Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.

Vertebral body mesenchymal stem cells derived from whole bone marrow aspirate may provide alternative stem cell sources for spine surgery applications, according to a study in Spine.

LifeNet Health launched the PliaFX Prime allograft surgical solution.

Cellect Biotechnology's ApoGraft technology demonstrated positive results for orthopedic applications in a study.

Kuros Biosciences submitted an FDA 510(k) clearance regulatory package for its Fibrin-PTH (KUR-113).

Reinvent Biologics is a regenerative medicine company.

Platelet-rich plasma injections and stem cell therapies are ushering in a "new dawn" in orthopedics, according to Jason Arora, DO, a board-certified interventional spine and pain management physician at West Orange, N.J.-based Atlantic Spine Center.

Cynata Therapeutics entered into a licensing agreement with Fujifilm Holdings to begin stem cell therapy clinical trials in the U.S. and Japan, according to Nikkei Asian Review.

New York City-based Hospital for Special Surgery researchers launched a clinical trial to assess the effects of Organogenesis' ReNu on knee function.

A stem cell provider registry program will improve the quality of treatments, wrote Fabio Rossi, MD, PhD, and Judy Illes, PhD, in an op-ed in the Vancouver Sun.

Baxter International received FDA 510(k) clearance for its Altapore Bioactive Bone Graft for spinal fusion.